Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2026-01-19 @ 11:30 PM
Study NCT ID:
NCT01884961
Status:
COMPLETED
Last Update Posted:
2025-01-13
First Post:
2013-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2
Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-19
First Submit QC Date:
None
Study First Post Date:
2013-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-10
Last Update Post Date:
2025-01-13
Last Update Post Date Type:
ACTUAL